$Karyopharm Therapeutics (KPTI.US)$Reuters· 5 mins ago Karyopharm Announces Favorable Change in Co-Primary Endpoint for Pivotal Phase 3 Sentry Trial in Myelofibrosis
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more